Cargando…
Clinical significance of decreased programmed cell death 4 expression in patients with giant cell tumors of the bone
Programmed cell death 4 (PDCD4) has been recognized as a novel tumor suppressor gene, which inhibits the activation and translation of activator protein (AP)-1. Dysregulated expression of PDCD4 is also involved in various human tumors and is linked to tumor progression and development. However, the...
Autores principales: | Gao, Fei, Zhang, Wei, Ding, Lingling, Zhao, Miaoqing, Ma, Zhe, Huang, Shanying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096107/ https://www.ncbi.nlm.nih.gov/pubmed/30127992 http://dx.doi.org/10.3892/ol.2018.9087 |
Ejemplares similares
-
Expression of ezrin, CD44, and VEGF in giant cell tumor of bone and its significance
por: Zhang, Jing, et al.
Publicado: (2015) -
Clinical Significance of MRI and Pathological Features of Giant Cell Tumor of Bone Boundary
por: Chen, Liang, et al.
Publicado: (2019) -
Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone
por: Lipplaa, Astrid, et al.
Publicado: (2019) -
Expression of osteoprotegerin and osteoprotegerin ligand in giant cell tumor of bone and its clinical significance
por: YU, XIUCHUN, et al.
Publicado: (2013) -
Prognostic significance of the preoperative neutrophil-to-lymphocyte ratio patients with giant cell tumor of bone
por: Yapar, Aliekber, et al.
Publicado: (2021)